India’s largest drugmaker, Sun Pharma, is considering a major acquisition. The company is evaluating the purchase of US-based Organon, a specialist in women’s health. This potential deal is valued at around $10 billion. A successful acquisition would be a significant move for Sun Pharma, strengthening its presence in the US market.